Business Daily Media

Men's Weekly

.

Sai Life Sciences' pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan

  • Written by PR Newswire
Sai Life Sciences' pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan

HYDERABAD, India, Dec. 1, 2021 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization[1] (CRO/ CDMO), today announced that the Japanese regulatory agency, Pharmaceuticals and Medical Devices Agency (PMDA) completed a paper-based compliance inspection of its intermediate & API manufacturing facility[2] in Bidar, India and issued a Certificate of Inspection. Previously, the agency had conducted a three-day long physical audit in the year 2016 and had issued a Certificate of Inspection.

Making the announcement, Krishna Kanumuri, CEO & Managing Director, said, "We are delighted to receive a formal Certificate of Inspection from PMDA, Japan. We have been a reliable supplier of pharmaceutical API to the Japanese market for over five years and this certification is a reaffirmation of our commitment to fulfil the most stringent quality standards of the regulatory agency."

Sai Life Sciences has a growing presence in the Japanese market. It was the launch site for commercial API supplies[3] of an NCE to Japan and has supplied over 50 tonnes of API over the past five years. It is a supplier of registered starting materials for three commercial APIs. The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product. From a drug discovery perspective, the company has helped several biotech and pharma companies advance programs from HIT to lead optimization/ candidate stage[4], through its chemistry[5], biology[6] and DMPK services[7]. The company opened its representative office in Tokyo[8], Japan last year, which serves as base for the company's outreach to innovator pharmaceutical and biotech companies in Japan and other countries in the Asia Pacific region.

Some of the notable highlights of the Bidar manufacturing facility of Sai Life Sciences:

  • 100% track record of successful inspections –
  • USFDA (4 times)
  • PMDA (twice)
  • COFEPRIS, Mexico (once)
450KL capacity with 50 production trains Containment level of 1µg/m3 0.25 – 10 KL reactor sizes 21CFR compliant single fluid automation system 7 clean rooms & 4 suits of ISO – 8 (Class 100,000) Lyophilization at pilot & commercial scale Chromatography at commercial scale Cryo reactions at 2.5 KL, 4 KL & 5 KL scale Highly Potent API facility (Q1-2022) Amidites facility (Q1-2022) Upcoming facilities
  • Dedicated facility for companion animal health products
  • Additional 200KL intermediate and API manufacturing capacity
ISO 14001:2015 and ISO 45001:2018 certified Zero liquid discharge facility Multiple awards for excellence in energy management and EHS practices.

About Sai Life Sciences

Sai Life Sciences is a full-service CRO-CDMO that works with innovator pharma and biotech companies globally, to accelerate the discovery, development and commercialisation of complex small molecules. The company has over 2200 employees across its facilities in India, UK and USA. Sai Life Sciences is privately held and backed by global investors, TPG Capital and HBM Healthcare Investments. https://www.sailife.com/[9][10]

Sai Life Sciences' pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan Sai Life Sciences’ pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan

 

References

  1. ^ global Contract Research, Development & Manufacturing Organization (www.sailife.com)
  2. ^ intermediate & API manufacturing facility (www.sailife.com)
  3. ^ commercial API supplies (www.sailife.com)
  4. ^ HIT to lead optimization/ candidate stage (www.sailife.com)
  5. ^ chemistry (www.sailife.com)
  6. ^ biology (www.sailife.com)
  7. ^ DMPK services (www.sailife.com)
  8. ^ representative office in Tokyo (www.sailife.com)
  9. ^ full-service CRO-CDMO (www.sailife.com)
  10. ^ https://www.sailife.com/ (www.sailife.com)

Read more https://www.prnasia.com/story/archive/3591521_AE91521_0

Small-Business Cash-Flow Playbook 2025

An educational guide to managing ATO debt, real-time super and growth finance in Australia’s new landscape Why ATO debt just became the most expe...

Landowners Offered $30,000 Per Year for Just 1 Hectare: The Rise of 5MW Battery Projects Across Australia

In a pivotal shift reshaping Australia’s renewable energy landscape, landowners in Queensland, New South Wales, and Victoria are being offered up ...

Major national security tech alliance launches with Aerologix a founding member

Australia’s leading drone intelligence pioneer bolsters sovereign tech power Australia’s leading aerial data and drone intelligence platform, Aer...

Chris Hancock AM Honoured as 2025 Communications Ambassador

SYDNEY Chris Hancock AM, former CEO of AARNet, has been awarded the prestigious Communications Ambassador title at the 2025 Telecommunications Indus...

Baby boomers are driving development feasibility leading to larger apartments

As residential developers continue to grapple with feasibility issues on apartment projects, the sector is struggling to deliver volumes of new st...

Hays launches FY25/26 Salary Guide: ‘Salary Paradox’ deepens as pay rises fail Australians

Rising dissatisfaction with pay, progression and perks is fuelling a new wave of career change in FY25/26, as Australians demand more from employe...

Sell by LayBy